Who
Oswald Gayle
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Innovative Eyewear.
In numbers
- Trades disclosed
- 20
- Buys
- 1
- Sells
- 6
- Bought
- $3,338
- Sold
- $49K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 3 Apr 2025
- Last trade
- 19 Aug 2026
- Last filed
- 24 Aug 2026
Companies traded
Activity over time
1 Mar 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 19 Aug 2026filed 24 Aug 2026 | LUCY Innovative EyewearMedical Devices | SEC FORM 4 Code A | —16,233 at $0.00 | filing |
| 19 Aug 2026filed 24 Aug 2026 | LUCY Innovative EyewearMedical Devices | SEC FORM 4 Sold | $5,3687,959 at $0.6745 | filing |
| 19 Aug 2026filed 24 Aug 2026 | LUCY Innovative EyewearMedical Devices | SEC FORM 4 Code A | —16,233 at $0.00 | filing |
| 19 Aug 2026filed 24 Aug 2026 | LUCY Innovative EyewearMedical Devices | SEC FORM 4 Sold | $5,3337,959 at $0.67 | filing |
| 2 Apr 2026filed 24 Aug 2026 | LUCY Innovative EyewearMedical Devices | SEC FORM 4 Code A | —16,233 at $0.00 | filing |
| 2 Apr 2026filed 24 Aug 2026 | LUCY Innovative EyewearMedical Devices | SEC FORM 4 Sold | $8,1237,574 at $1.07 | filing |
| 2 Apr 2026filed 24 Aug 2026 | LUCY Innovative EyewearMedical Devices | SEC FORM 4 Code A | —16,233 at $0.00 | filing |
| 2 Apr 2026filed 24 Aug 2026 | LUCY Innovative EyewearMedical Devices | SEC FORM 4 Sold | $8,1047,574 at $1.07 | filing |
| 13 Jan 2026filed 15 Jan 2026 | LUCY Innovative EyewearMedical Devices | SEC FORM 4 Bought | $1,162700 at $1.66 | filing |
| 13 Jan 2026filed 15 Jan 2026 | LUCY Innovative EyewearMedical Devices | SEC FORM 4 Bought | $507300 at $1.69 | filing |
| 13 Jan 2026filed 15 Jan 2026 | LUCY Innovative EyewearMedical Devices | SEC FORM 4 Bought | $1,162700 at $1.66 | filing |
| 13 Jan 2026filed 15 Jan 2026 | LUCY Innovative EyewearMedical Devices | SEC FORM 4 Bought | $507300 at $1.69 | filing |
| 23 Sep 2025filed 9 Jan 2026 | LUCY Innovative EyewearMedical Devices | SEC FORM 4 Sold | $4,0471,865 at $2.17 | filing |
| 19 Aug 2025filed 9 Jan 2026 | LUCY Innovative EyewearMedical Devices | SEC FORM 4 Code A | —5,400 at $0.00 | filing |
| 19 Aug 2025filed 9 Jan 2026 | LUCY Innovative EyewearMedical Devices | SEC FORM 4 Sold | $3,4071,670 at $2.04 | filing |
| 10 Apr 2025filed 9 Jan 2026 | LUCY Innovative EyewearMedical Devices | SEC FORM 4 Sold | $4,8841,789 at $2.73 | filing |
| 10 Apr 2025filed 9 Jan 2026 | LUCY Innovative EyewearMedical Devices | SEC FORM 4 Sold | $2,560895 at $2.86 | filing |
| 10 Apr 2025filed 9 Jan 2026 | LUCY Innovative EyewearMedical Devices | SEC FORM 4 Sold | $2,676895 at $2.99 | filing |
| 3 Apr 2025filed 9 Jan 2026 | LUCY Innovative EyewearMedical Devices | SEC FORM 4 Code A | —5,400 at $0.00 | filing |
| 3 Apr 2025filed 9 Jan 2026 | LUCY Innovative EyewearMedical Devices | SEC FORM 4 Sold | $4,2611,821 at $2.34 | filing |
News
Portfolio Company Update – Innovative Eyewear Inc | Company AnnouncementLUCY · investegate.co.uk · 19 Oct 2026Comparing NeuroOne Medical Technologies (NASDAQ:NMTC) and Innovative Eyewear (NASDAQ:LUCY)LUCY · tickerreport.com · 11 Oct 2026
0 headlines in the last 90 days name Oswald Gayle; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.